Advertisement
12/06/2019

Dr. Reddy's debuts 2 generics

Sandra Levy
Senior Editor
Sandra Levy profile picture

Dr. Reddy’s is launching deferasirox tablets for oral suspension.

The product is the generic of Novartis’ Exjade (deferasirox) tablets for oral suspension.

The Exjade brand had a market value of roughly $113 million for the most recent 12 months ending in September 2019, according to IQVIA.

Dr. Reddy’s also is introducing deferasirox film-coated tablets in dosage strengths of 90 mg and 360 mg.

The product is the generic of Novartis’ Jadenu (deferasirox) film-coated tablets, 90 mg, 180 mg, and 360 mg.

Jadenu had a market value of approximately $470 million for the most recent 12 months ending in September 2019, according to IQVIA.

Dr. Reddy’s product comes in bottle count sizes of 30.

Advertisement
Advertisement